Transaction Details:

Hash 59989b15b2857c9dc1c19b25346f6fb9409cd858303cf208a188f506c2fa7eba
Blockhash 2f41d628abd5ece4ccfd3df7bf94dad043d64eb8f35ccd4ca212101d8824ff3f
Blocktime 2019-10-17 07:56
Confirmations 120082

Inputs

Index Previous Output Address
0 b84118ee5c06230cc81096449efb62cfaac790238bca2332cd66b0091e1bd7f3:1 b'2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd'

Outputs

Index Redeemed in Address Amount
0 Not yet redeemed N/A 0 CBL
1 e751fd8df336db63558b6297d96907406ceca4ae1dc617c6b4ba0bbcf58fbed9 2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd 99.99980831 CBL
{
"txid": 59989b15b2857c9dc1c19b25346f6fb9409cd858303cf208a188f506c2fa7eba,
"time": 1571299005,
"blocktime": 1571299005,
"blockhash": 2f41d628abd5ece4ccfd3df7bf94dad043d64eb8f35ccd4ca212101d8824ff3f,
"confirmations": 120082,
"vin ": [
{
"txid": b84118ee5c06230cc81096449efb62cfaac790238bca2332cd66b0091e1bd7f3
"vout": 1
"scriptSig": {'asm': '304402203728d388d7bd35b2dc56a7ebc7037944025ca0d7788b3a4b4ec5c8400eba514402205a4669dcd0719540b948a16b4718719d32ee1927c46ca0a873bc4c28f3480aac01 03f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38', 'hex': '47304402203728d388d7bd35b2dc56a7ebc7037944025ca0d7788b3a4b4ec5c8400eba514402205a4669dcd0719540b948a16b4718719d32ee1927c46ca0a873bc4c28f3480aac012103f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38'}
"sequence": 4294967295
}
],
"vout ": [
{
"value": 0
"n": 0
"scriptPubKey": {
"asm": 73706b65164ff70a0a0153ccf31bbaf3f020c19d OP_DROP 73706b6b43434231374657646e64674b41 OP_DROP 73706b6b435434784e6141587a784a6d4e OP_DROP 73706b6b434474434565504e4b69525169 OP_DROP 73706b6b43523561707163767453393245 OP_DROP 73706b6602 OP_DROP OP_RETURN 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
"hex": 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
"type": nulldata
},
"items": [
{'type': 'stream', 'name': 'iscc', 'createtxid': '9dc120f0f3ba1bf3cc53010a0af74f164961f37595bdd9a89b5064e60304c070', 'streamref': '22580-300-49565', 'publishers': ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd'], 'keys': ['CCB17FWdndgKA', 'CT4xNaAXzxJmN', 'CDtCEePNKiRQi', 'CR5apqcvtS92E'], 'offchain': False, 'data': {'json': {'title': 'praklinische prufung von neuem bispezifischem antikorper beim myelom', 'tophash': '1a2a06287868b5f7ec21f8d2448ef38afb069640c44221fce449eaccbcac3601', 'meta': [{'schema': 'schema.org', 'mediatype': 'application/ld+json', 'data': {'@context': 'http://schema.org/', '@type': 'ScholarlyArticle', 'datePublished': '2016-12-01', 'encoding': [{'@type': 'MediaObject', 'contentUrl': 'https://link.springer.com/content/pdf/10.1007%2Fs15015-016-3042-8.pdf', 'encodingFormat': 'application/pdf'}], 'genre': 'journal-article', 'identifier': [{'@type': 'PropertyValue', 'propertyID': 'DOI', 'value': '10.1007/s15015-016-3042-8'}, {'@type': 'PropertyValue', 'propertyID': 'ISCC', 'value': 'CCB17FWdndgKA-CT4xNaAXzxJmN-CDtCEePNKiRQi-CR5apqcvtS92E'}], 'name': 'Präklinische Prüfung von neuem bispezifischem Antikörper beim Myelom', 'publisher': {'@type': 'Organization', 'name': 'Springer Nature'}, 'author': [{'@type': 'Person', 'name': 'Silke Wedekind'}]}}]}}}
]
},
{
"value": 99.99980831
"n": 1
"scriptPubKey": {
"asm": OP_DUP OP_HASH160 70f3924b82ad8ba9ca4b38ee85a83bd99c142f9f OP_EQUALVERIFY OP_CHECKSIG
"hex": 76a91470f3924b82ad8ba9ca4b38ee85a83bd99c142f9f88ac
"reqSigs": 1
"type": pubkeyhash
"addresses": ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd']
}
}
]
}